You took the medication every day and gave it time. Maybe the dose changed. Maybe you tried a second prescription or added counseling. Yet getting through work, keeping up with responsibilities, or feeling interested in the things you normally enjoy is still difficult.

That is often when people start looking into other depression treatment options. For adults in Milwaukee, the next step does not always mean trying another antidepressant without a larger conversation. It may mean reviewing what you have already tried, whether those treatments had enough time to work, what symptoms remain, and whether another type of care should be considered.

At VIVA Ketamine Infusion Center of Milwaukee, we work with adults who are exploring medically supervised IV ketamine after traditional mental health care has not provided enough relief. Ketamine is not right for every person, and it does not replace the need for a careful medical evaluation. Understanding where it fits can make the next treatment conversation much more useful.

Which Depression Treatment Options Come After Antidepressants?

Depression treatment options when medication has not provided enough relief may include changing the medication or dose, adding psychotherapy, combining medications, brain stimulation treatments, esketamine, or medically supervised IV ketamine for appropriate patients. The next step depends on how many treatments you have tried, how long you used them, your remaining symptoms, side effects, health history, and the level of depression you are experiencing.

What Does It Actually Mean When an Antidepressant Has Not Been Enough?

A disappointing response to one prescription does not automatically mean that all traditional depression treatment has failed.

Antidepressants generally need time to work. The National Institute of Mental Health notes that antidepressants often take four to eight weeks to have an effect. A provider may also need to consider the dose, whether the medication was taken consistently, side effects, and whether symptoms changed at all before deciding what should happen next. You can review the broader NIMH depression guide for information about medication, psychotherapy, and other forms of depression care.

There is also a difference between no response and partial response. One person may notice that sleep and concentration have improved while low mood and lack of interest remain. Another may feel almost no change. Someone else may stop a medication because the side effects are difficult to tolerate.

Those situations can lead to different decisions.

Treatment-resistant depression is generally used to describe depression that has not improved after at least two adequate antidepressant trials. That does not mean everyone who meets that description should receive the same next treatment. It means there may be a reason to discuss options outside another routine medication trial.

How Do the Next Treatment Choices Differ?

Several forms of care can be considered when depression remains difficult to manage, but they do different things and involve different treatment experiences. A medication adjustment may still make sense when someone received some benefit from an antidepressant or has not yet completed an adequate trial. A prescribing provider may consider changing the dose, using another antidepressant, or adding a second medication.

Psychotherapy can remain part of treatment even when medication has not worked well. Someone who has primarily relied on medication may benefit from adding counseling. A person already in therapy may continue that relationship while exploring another medical treatment.

Brain stimulation therapies such as transcranial magnetic stimulation, commonly called TMS, and electroconvulsive therapy, or ECT, are also used for certain forms of depression. These treatments do not use medication to create their primary therapeutic effect. They stimulate brain activity in different ways and involve their own treatment schedules and medical considerations.

Esketamine is another option that sometimes comes up during this conversation. Esketamine is related to ketamine, but it is not the same treatment as an IV ketamine infusion. It is delivered as a nasal spray in a medically supervised setting and is FDA-approved for treatment-resistant depression in adults.

IV ketamine is different. Ketamine itself has FDA approval as an anesthetic, while its use through IV infusion for depression is off-label. Low-dose IV ketamine has been studied for treatment-resistant depression because it affects glutamate signaling in the brain rather than working through the same pathways targeted by many traditional antidepressants.

None of these choices should be viewed as an automatic next step. What makes sense for someone who has tried one medication may be very different from what makes sense for someone who has spent years trying several medications, counseling, and other treatments.

Where Does IV Ketamine Fit Into Depression Care?

IV ketamine may enter the conversation when traditional treatment has not produced enough improvement and a medical provider determines that the person may be an appropriate candidate.

At VIVA, we do not start by assuming someone needs an infusion. The process begins with a consultation with one of our nurse practitioners. That appointment includes a review of medical history, current medications, previous mental health care, symptoms, and treatment goals.

This gives us information that cannot be learned simply by knowing that someone has depression. Two people may both say that antidepressants have not helped, while having very different medication histories, health concerns, symptom patterns, and previous treatment experiences.

Our personalized planning reflects those differences. Medications are reviewed before treatment, and the treatment schedule can be discussed based on the individual rather than assuming every person arrives with the same needs.

For patients who move forward, VIVA administers ketamine through an IV at low, subanesthetic doses. Our typical starting protocol includes six infusions over two to three weeks. Maintenance treatments may be considered later based on the patient’s response and ongoing needs.

That structure is important when comparing IV ketamine with taking a daily medication. An infusion is a scheduled clinical appointment rather than a prescription taken at home each morning. It also allows the provider to control how quickly medication enters the bloodstream during treatment.

What Makes VIVA’s IV Treatment Different From Taking Medication at Home?

The treatment setting is one of the most practical differences. At VIVA Ketamine Infusion Center of Milwaukee, patients receive their infusion in a private clinical environment with direct medical observation. Ketamine can temporarily affect blood pressure, pulse, awareness, and perception, so the provider follows both physical changes and how the patient is responding during the session.

Vital signs may include blood pressure, pulse, breathing rate, and oxygen levels. Because the medication is delivered through an IV, the infusion can also be slowed, paused, or stopped if the patient’s response needs more attention.

Our medical monitoring continues beyond simply checking numbers on a screen. The provider can assess whether the patient is alert, comfortable, able to communicate, and recovering as expected.

Patients also have time to rest after the infusion before leaving. Transportation needs are reviewed as part of treatment planning because patients need someone else to drive them home after an infusion.

This is one reason different ketamine services should not be compared based on the medication name alone. IV treatment in a clinic, nasal medication, oral ketamine products, and at-home programs can involve different delivery methods and different levels of direct medical observation.

When This Matters

A different treatment conversation may make sense when depression continues to affect daily life even though you have made reasonable attempts to address it.

You may have tried two or more antidepressants and still find it difficult to get through normal responsibilities. You may be able to go to work but have very little energy left afterward. You may have continued counseling while still experiencing persistent low mood, lack of interest, problems concentrating, or a sense that your current treatment has reached a limit.

It can also matter when an antidepressant helps somewhat but leaves significant symptoms behind. A partial response is still worth discussing because the goal of treatment is not simply to notice any change. Your provider needs to understand how much the remaining symptoms are affecting your life.

This does not mean IV ketamine is needed whenever someone dislikes an antidepressant or has been taking one without immediate improvement. Someone who recently started a first medication may need more time or a different adjustment. Another person may benefit from psychotherapy, a medication change, or another form of depression treatment instead.

Ketamine also requires medical screening. Certain health concerns, medications, or other factors can affect whether treatment is appropriate. That is why an outpatient ketamine consultation is different from simply requesting a specific medication.

If depression has reached the point of an immediate mental health emergency or there is an immediate risk of self-harm, urgent crisis or emergency care should take priority over waiting for a routine ketamine consultation.

Who Is VIVA Ketamine Care Designed For?

The adults who contact our Brookfield clinic are often not starting their first conversation about mental health treatment.

Some have spent months or years trying different antidepressants. Others have combined medication with counseling but still feel that depression is limiting their daily lives. Some want to understand whether a treatment that works differently from their previous medications could be considered.

VIVA provides medically supervised ketamine care for patients who have completed the consultation process and are appropriate candidates. Our current clinical staff includes nurse practitioners with direct ketamine experience, along with Medical Director Dr. Alex Beugelsdijk, whose psychiatry residency included extensive training in ketamine treatment for treatment-resistant depression.

That experience matters because ketamine treatment involves more than administering medication. Providers need to review the patient’s history, screen for factors that may affect treatment, monitor the infusion, evaluate the response, and help determine what should happen after the initial treatment series.

IV ketamine can also exist alongside other mental health care. Someone may continue working with their psychiatrist, therapist, primary care provider, or other mental health professional while receiving ketamine infusions. Medication changes should be discussed with the appropriate prescribing provider rather than made independently.

Discuss Depression Treatment Options in Milwaukee

When an antidepressant has not provided enough relief, the next step should be based on more than simply choosing another treatment from a list. Your medication history, response to previous care, remaining symptoms, health history, and treatment goals all help determine which depression treatment options deserve consideration.

For some adults in Milwaukee, medically supervised IV ketamine may be one of those options. At VIVA Ketamine Infusion Center of Milwaukee, treatment begins with a consultation at our Brookfield clinic so we can review your history, discuss your questions, and determine whether IV ketamine may be appropriate for you.

If you have already tried traditional depression treatment and still feel that something is missing, contact VIVA Ketamine Infusion Center of Milwaukee to schedule a consultation and learn what the next step could look like.